Xiaolan Bian

510 total citations
37 papers, 375 citations indexed

About

Xiaolan Bian is a scholar working on Pharmacology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Xiaolan Bian has authored 37 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 7 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Xiaolan Bian's work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Xiaolan Bian is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). Xiaolan Bian collaborates with scholars based in China, United States and Netherlands. Xiaolan Bian's co-authors include Ping Yu, Zhitao Yang, Liang Zhang, Wenpei Dong, Min Li, Jing Yuan, Bing Han, Hai‐Shu Lin, Yiqun Yu and Yan‐Ru Lou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Journal of Pharmacology.

In The Last Decade

Xiaolan Bian

34 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Bian China 11 135 97 85 67 50 37 375
Yaxin Fan China 11 180 1.3× 148 1.5× 71 0.8× 78 1.2× 24 0.5× 40 337
Chunhong Zhang China 12 98 0.7× 35 0.4× 99 1.2× 34 0.5× 15 0.3× 38 376
Hsin-Yi Liu Taiwan 7 43 0.3× 124 1.3× 102 1.2× 126 1.9× 59 1.2× 8 392
Iulia Cristina Bagiu Romania 11 44 0.3× 36 0.4× 145 1.7× 52 0.8× 21 0.4× 35 417
Atsushi Uda Japan 11 45 0.3× 23 0.2× 73 0.9× 28 0.4× 50 1.0× 26 298
Yangang Zhou China 11 85 0.6× 93 1.0× 71 0.8× 54 0.8× 24 0.5× 27 287
Hervé Delacour France 11 94 0.7× 98 1.0× 97 1.1× 20 0.3× 33 0.7× 49 342
Hadi Zare Marzouni Iran 11 34 0.3× 46 0.5× 153 1.8× 82 1.2× 16 0.3× 33 618
Rajbharan Yadav United States 16 243 1.8× 276 2.8× 124 1.5× 118 1.8× 78 1.6× 29 567
Junko Nagai Japan 12 154 1.1× 23 0.2× 92 1.1× 27 0.4× 8 0.2× 35 403

Countries citing papers authored by Xiaolan Bian

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Bian more than expected).

Fields of papers citing papers by Xiaolan Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Bian. The network helps show where Xiaolan Bian may publish in the future.

Co-authorship network of co-authors of Xiaolan Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Bian. A scholar is included among the top collaborators of Xiaolan Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Bian. Xiaolan Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Aiqin, et al.. (2025). Towards zebrafish model applications in drug discovery targeting central nervous system diseases and neurotoxicity assessment. European Journal of Pharmacology. 1002. 177776–177776. 1 indexed citations
2.
Li, Hui, Xiaodong He, Ling Wang, et al.. (2025). Unexpected renal influence on isavuconazole trough concentrations: two case reports and literature review. Frontiers in Medicine. 12. 1625697–1625697.
3.
Zhao, Juntao, Xiaoli Ma, Shu Chen, et al.. (2025). Antibody-free quantification of serum infliximab using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 266. 117117–117117.
4.
Cheng, Xia, Wenchen Zhao, Xinyi Xia, et al.. (2024). RNA transcription assisted universal CRISPR/Cas12a system for programmable analysis of multiple colorectal cancer-associated microRNAs. Talanta. 282. 126960–126960. 6 indexed citations
6.
He, Xuan, Jie Fang, Ping Yü, et al.. (2023). Risk of reactive cutaneous capillary endothelial proliferation induced by camrelizumab in patients with non-small cell lung cancer: a retrospective study. Journal of Thoracic Disease. 15(12). 6687–6696. 3 indexed citations
7.
Chen, Dayu, Bing Zhao, Linyu Wang, et al.. (2023). Prognostic performance of the NRS2002, NUTRIC, and modified NUTRIC to identify high nutritional risk in severe acute pancreatitis patients. Frontiers in Nutrition. 10. 1101555–1101555. 4 indexed citations
9.
Yu, Ping, et al.. (2022). Research progress regarding long-chain non-coding RNA in lung cancer: a narrative review. Journal of Thoracic Disease. 14(8). 3016–3029. 11 indexed citations
10.
Du, Ning, Enqiang Mao, Zhitao Yang, et al.. (2022). Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae. Infection and Drug Resistance. Volume 15. 7219–7226. 2 indexed citations
11.
Xu, Doudou, Hui Li, Gang Xu, et al.. (2022). Impact of Long-Term Home Quarantine on Mental Health and Physical Activity of People in Shanghai During the COVID-19 Pandemic. Frontiers in Psychiatry. 12. 782753–782753. 9 indexed citations
13.
Li, Haonan, Min Fan, Kui Wang, et al.. (2022). Traditional Chinese medicine extracts as novel corrosion inhibitors for AZ91 magnesium alloy in saline environment. Scientific Reports. 12(1). 7367–7367. 5 indexed citations
14.
Yu, Ping, Tianwei Qian, Qiaoyun Gong, et al.. (2021). Inflammatory cytokines levels in aqueous humour and surgical outcomes of trabeculectomy in patients with prior acute primary angle closure. Acta Ophthalmologica. 99(7). e1106–e1111. 6 indexed citations
17.
Yu, Yiqun, Xiaolan Bian, Yao Li, et al.. (2021). Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling. Archives of Toxicology. 95(5). 1683–1701. 60 indexed citations
18.
Zheng, Xiaoxiao, Bing Zhao, Ping Yu, et al.. (2021). Vitamin C reduces vancomycin-related nephrotoxicity through the inhibition of oxidative stress, apoptosis, and inflammation in mice. Annals of Translational Medicine. 9(16). 1319–1319. 20 indexed citations
19.
Yu, Ping, Wenpei Dong, Ya‐Bin Tang, et al.. (2021). Huperzine A lowers intraocular pressure via the M3 mAChR and provides retinal neuroprotection via the M1 mAChR: a promising agent for the treatment of glaucoma. Annals of Translational Medicine. 9(4). 332–332. 14 indexed citations
20.
Xiao, Jianzhong, et al.. (2014). Cost-effectiveness of switching to biphasic insulin aspart from human premix insulin in people with type 2 diabetes in China. Value in Health. 17(3). A250–A250. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026